First patient included in the clinical trial at Helsingborg hospital.
The first patient was included in end of Janury 2023 and a total of thirty eight (38) patients will be included to complete the clinical trial. The primary objective of the study is to evaluate the clinical performance of Suture TOOL for abdominal wall closure in men and women undergoing open abdominal surgery (laparotomy), in terms of the proportion of patients with an SL/WL ratio ≥ 4.
“We are so happy that we finally have included the first patient and the clinical trial is so important, because it is the last step before Suturion introduces the device in the market”, says Gabriel Börner, founder and chief medical officer.
Watch on Youtube here